Peptide Mass Spectrometry: What Confirms a CoA’s Identity Line

Reading the Report — Part 3 of the series.

On a peptide Certificate of Analysis, one line does the quietest and most important job of all: Identity. On our anchor document — the BPC-157 10 mg CoA, Lot APS26-0144 — it reads simply “BPC-157 ✓.” That checkmark looks like a formality. It isn’t. It’s the analytical answer to the single most consequential question a researcher can ask about a vial: is the compound in here actually the compound on the label? The technique that answers it is peptide mass spectrometry, and this post explains what stands behind that checkmark.

In Part 1 https://apexpeptidesupply.com/how-to-read-peptide-certificate-of-analysis/ we walked the CoA line by line. In Part 2 we looked at HPLC purity and what “99.8%” really means. Purity and identity are often confused, so it’s worth being precise: purity tells you how much of the material is your main component; identity tells you what that main component is. A sample can be 99.8% pure and still be 99.8% of the wrong molecule. Mass spectrometry is what closes that gap.

What “identity confirmation” actually means

Every peptide has a defined amino acid sequence, and that sequence fixes an exact molecular formula and therefore an exact mass. BPC-157 is a pentadecapeptide (fifteen residues) with the formula C62H98N16O22. From that formula alone, its mass is a known quantity — no measurement required. Identity confirmation is the act of measuring the mass of the material in the vial and checking it against that theoretical value. If they agree within the analytical tolerance, the measured molecule is consistent with the intended structure. If they don’t, something is wrong — a synthesis error, a mislabel, a deletion sequence, or a different compound entirely.

How a mass spectrometer sees a peptide

A mass spectrometer doesn’t weigh molecules the way a balance weighs powder. It does three things in sequence:

1. Ionize the molecules — give them an electrical charge so they can be manipulated by electric and magnetic fields.
2. Separate the resulting ions by their mass-to-charge ratio (written m/z).
3. Detect how many ions arrive at each m/z value, producing a spectrum of peaks.

Two ionization methods dominate peptide work, and you’ll see one or the other referenced on a CoA:

• ESI (electrospray ionization) sprays the peptide out of solution and tends to add multiple charges to a single molecule. A peptide of BPC-157’s size typically appears as a family of peaks rather than one.
• MALDI (matrix-assisted laser desorption/ionization) uses a laser and a crystalline matrix, and usually produces singly charged ions — often a single dominant peak.

Neither is “better”; they’re different windows onto the same molecule. What matters is that the mass they report matches the mass the sequence predicts.

Theoretical mass: average vs. monoisotopic

Here’s where a lot of confusion starts. A single peptide has two commonly cited “correct” masses, and they aren’t the same number:

• Average mass — for BPC-157, about 1419.56 Da. This is the weighted average across all naturally occurring isotopes of each element.
• Monoisotopic mass — for BPC-157, about 1418.70 Da. This is calculated using only the single most abundant isotope of each element (¹²C, ¹H, ¹⁴N, ¹⁶O).

The roughly 0.85 Da difference is real and expected. Which one the lab reports depends on the instrument’s resolution: high-resolution instruments resolve the individual isotope peaks and report the monoisotopic mass, while lower-resolution instruments report the average. A CoA that lists an observed mass near 1419.6 and one that lists ~1418.7 are not contradicting each other — they’re describing the same molecule with two different conventions. Knowing this is what keeps a researcher from flagging a perfectly good result as a discrepancy.

Reading the charge-state ladder (ESI)

Because ESI adds multiple protons, an electrospray spectrum of a ~1420 Da peptide shows a ladder of peaks, each corresponding to a different number of added charges. The instrument reports m/z, so more charge means a lower apparent value. Using BPC-157’s average mass as an illustration:

• [M+H]+ (1 charge) → m/z ≈ 1420.6
• [M+2H]2+ (2 charges) → m/z ≈ 710.8
• [M+3H]3+ (3 charges) → m/z ≈ 474.2

Analytical software runs this in reverse — a step called deconvolution — collapsing the whole ladder back into a single molecular mass. That deconvoluted mass is the number worth comparing to theory. If you ever see several unexplained peaks and wonder whether the sample is contaminated, remember that a clean multiply-charged envelope is the normal signature of a single pure peptide, not evidence of a problem.

What “matches” means: mass accuracy and tolerance

No measurement is infinitely precise, so identity confirmation is never “exactly 1418.704.” It’s “within tolerance.” Reputable labs state the observed mass and confirm it falls within the instrument’s expected error window. On a well-run peptide analysis that window is small — often a fraction of a Dalton on high-resolution instruments. The practical takeaway for anyone reading the report: identity is a pass/fail against a defined tolerance, and the CoA should let you see both the observed value and the conclusion, not just a bare checkmark.

What mass spectrometry can — and can’t — catch

Mass spec is powerful precisely because mass is unforgiving. Many synthesis problems shift the mass in predictable ways, and a chemist can often read the failure directly off the number:

• Truncation / deletion sequences — a missing residue drops the mass by that residue’s exact weight, an easy flag.
• Oxidation — adds about 16 Da (relevant for peptides containing methionine, tryptophan, or cysteine).
• Deamidation — adds about 1 Da (relevant for peptides containing asparagine or glutamine).
• Salt / counter-ion adducts — synthetic peptides are frequently isolated as trifluoroacetate or acetate salts, which can appear as added mass if not accounted for.

What mass spectrometry cannot do on its own is distinguish molecules that share the same mass — isobaric and isomeric species. Two peptides with the same amino acid composition in a different order weigh exactly the same. A D-amino acid substituted for its L-counterpart weighs exactly the same. Mass alone can’t tell these apart. This is the core reason a CoA doesn’t rest on mass spec alone: it pairs identity (mass spectrometry) with purity and separation (the HPLC work from Part 2 https://apexpeptidesupply.com/peptide-hplc-purity/), and sometimes orthogonal methods, so the techniques cover each other’s blind spots. The strength of a report is the combination, not any single line.

Back to the report

So when you look at that “Identity: BPC-157 ✓” line, here’s what a careful reader is really confirming:

• An ionization method is named (ESI or MALDI).
• An observed mass is reported, not just a checkmark.
• That value is consistent with the theoretical mass — about 1419.56 Da average or about 1418.70 Da monoisotopic for BPC-157 — within the stated tolerance.
• The identity result is read alongside the purity data, not in isolation.

Identity confirmation is the difference between a document that asserts what’s in the vial and one that demonstrates it. In the next installment we’ll finish the CoA with the line researchers most often misread: net peptide content versus the quantity on the label — why “10 mg” on a vial and “10 mg of peptide” are not always the same thing.

Frequently asked questions

Does mass spectrometry prove a peptide is pure?
No. Mass spectrometry confirms the identity of the main component — that its mass matches the intended structure. Purity — how much of the total material is that component — is established primarily by HPLC. The two answer different questions and appear as separate lines on a Certificate of Analysis.

Why does a CoA sometimes list two different masses for one peptide?
A peptide has an average mass and a monoisotopic mass, which differ because they’re calculated using different isotope conventions. For BPC-157 the average mass is about 1419.56 Da and the monoisotopic mass is about 1418.70 Da. High-resolution instruments typically report the monoisotopic value; lower-resolution instruments report the average.

What are the multiple peaks in an electrospray (ESI) spectrum?
ESI adds several protons to each molecule, so a single peptide appears as a series of peaks at different charge states (for example [M+H]+, [M+2H]2+, [M+3H]3+). Software deconvolutes this ladder back into one molecular mass. A clean charge-state envelope is the normal signature of a single peptide, not a sign of contamination.

Can mass spectrometry detect every impurity?
No. Mass spectrometry cannot distinguish species that share the same mass, such as sequence isomers or D/L amino acid substitutions. This is why identity data is interpreted together with HPLC purity and, where appropriate, additional orthogonal methods, rather than on its own.

Research-use-only notice

All products supplied by Apex Peptide Supply are sold strictly for laboratory research use only (RUO). They are not drugs, foods, cosmetics, or medical devices, and are not intended for human or veterinary use, consumption, diagnosis, treatment, or the prevention of any disease. BPC-157 is referenced throughout this article solely as an analytical example — an analyte characterized by a Certificate of Analysis — and nothing here should be read as describing or implying any biological, clinical, or therapeutic effect. Handling of research compounds must be limited to qualified individuals in an appropriate laboratory setting, in accordance with all applicable laws and institutional requirements.